{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:57:29Z","timestamp":1781063849778,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.eimce.2026.503166","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:54:46Z","timestamp":1781020486000},"page":"503166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy of convalescent plasma for COVID-19 in the pre-vaccine era, and implementation in a large healthcare system: A phase I\/II randomized, multicentre clinical trial (PC-COVID)"],"prefix":"10.1016","volume":"44","author":[{"given":"Maria Giulia","family":"Caponcello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Mar","family":"Mac\u00edas-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Aguilar-Guisado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Romero Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Retamar-Gentil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"M\u00e1rquez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Mart\u00ednez-Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"L\u00f3pez C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Marrugal-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Quijano Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Carmona-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Oyonarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2026.503166_bib0090","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJMoa2119657","article-title":"Early outpatient treatment for COVID-19 with convalescent plasma","volume":"386","author":"Sullivan","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2026.503166_bib0095","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151788","article-title":"Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19","volume":"131","author":"Arnold Egloff","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.eimce.2026.503166_bib0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40009-8","article-title":"Convalescent plasma and all-cause mortality of COVID-19 patients: systematic review and meta-analysis","volume":"13","author":"Mihalek","year":"2023","journal-title":"Sci Rep"},{"issue":"Suppl_1","key":"10.1016\/j.eimce.2026.503166_bib0105","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1093\/cid\/ciac724","article-title":"Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19","volume":"78","author":"Bhimraj","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2026.503166_bib0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2021.11.007","article-title":"ESCMID COVID-19 living guidelines: drug treatment and clinical management","volume":"28","author":"Bartoletti","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimce.2026.503166_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105613","article-title":"Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial","volume":"113","author":"Hoffmann","year":"2025","journal-title":"eBioMedicine"},{"key":"10.1016\/j.eimce.2026.503166_bib0120","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa2033700","article-title":"Early high-titer plasma therapy to prevent severe COVID-19 in older adults","volume":"384","author":"Libster","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2026.503166_bib0125","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJMoa2119657","article-title":"Early outpatient treatment for COVID-19 with convalescent plasma","volume":"386","author":"Sullivan","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimce.2026.503166_bib0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2414957121","article-title":"Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma","volume":"121","author":"Dragotakes","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.eimce.2026.503166_bib0135","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.18632\/aging.202195","article-title":"Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: a systematic review with meta-analysis","volume":"13","author":"Wenjing","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.eimce.2026.503166_bib0140","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06829-7","article-title":"Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials","volume":"21","author":"Axfors","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimce.2026.503166_bib0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijid.2021.06.034","article-title":"Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial","volume":"109","author":"Hamilton","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.eimce.2026.503166_bib0150","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/microorganisms10051021","article-title":"Evaluation of the kinetics of antibody response to COVID-19 vaccine in solid organ transplant recipients: the prospective multicenter ORCHESTRA cohort","volume":"10","author":"Giannella","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.eimce.2026.503166_bib0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1433442","article-title":"The immune response to COVID-19 mRNA vaccination among lymphoma patients receiving anti-CD20 treatment","volume":"15","author":"Komlodi-Pasztor","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.eimce.2026.503166_bib0160","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.27.2100568","article-title":"SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data","volume":"26","author":"Nguyen","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.eimce.2026.503166_bib0165","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29603","article-title":"Convalescent plasma transfusion for immunocompromised viremic patients with COVID-19: a retrospective multicenter study","volume":"96","author":"Destremau","year":"2024","journal-title":"J Med Virol"},{"key":"10.1016\/j.eimce.2026.503166_bib0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1448720","article-title":"The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness","volume":"15","author":"So-Osman","year":"2024","journal-title":"Front Immunol"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X26000997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X26000997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:00:35Z","timestamp":1781060435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X26000997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2529993X26000997"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503166","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of convalescent plasma for COVID-19 in the pre-vaccine era, and implementation in a large healthcare system: A phase I\/II randomized, multicentre clinical trial (PC-COVID)","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica.","name":"copyright","label":"Copyright"}],"article-number":"503166"}}